MLND

SEC Form SC 13G filed by Millendo Therapeutics, Inc.

Millendo Therapeutics, Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

SEC Form 3: Versant Venture Capital VI, L.P. claimed ownership of 2,176,411 units of Common Stock

SEC Form 4 filed by Xu Stella

SEC Form 4 filed by Woiwode Thomas

SEC Form 4 filed by NICHOL GEOFFREY

SEC Form 4 filed by Pellizzari Christine A

SEC Form 3 filed by Pellizzari Christine A

SEC Form SC 13G filed by Millendo Therapeutics, Inc.

SEC Form 8-K/A filed by Millendo Therapeutics, Inc. (Amendment)

SEC Form 4: Whiting Samuel was granted 201 units of Common Stock

SEC Form 3 filed by Whiting Samuel

SEC Form 4: Xu Stella was granted 579,710 units of Common Stock

SEC Form 4: Dubensky Thomas W. was granted 111,343 units of Common Stock

SEC Form 4 filed by RAAB MICHAEL

SEC Form 4: Woiwode Thomas was granted 2,176,411 units of Common Stock

SEC Form 4 filed by Brady Stephen R

SEC Form 4: Lorenzo Pierre was granted 53 units of Common Stock

SEC Form 3 filed by Xu Stella

SEC Form 3 filed by Brady Stephen R

SEC Form 3 filed by RAAB MICHAEL

SEC Form 3 filed by Woiwode Thomas

SEC Form 3 filed by Lorenzo Pierre

SEC Form 3 filed by Dubensky Thomas W.

Millendo Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Changes in Control of Registrant, Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits